Early schizophrenia: long-acting oral and injectable antipsychotics have similar efficacy

by

To remember

  • Treatment with long-acting injectable antipsychotics (LPIs) does not appear to prevent more treatment discontinuations or offer an advantage over oral medications in patients with early-stage schizophrenia.

Why is this important?

  • Discuss API antipsychotic therapy with patients to determine if the benefits (maintenance of cognitive function, reduction in suicides, decreased risk of rehospitalization) outweigh the need for monthly injections.
Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

A week away from the Viña Festival: the lineup of comedians has not yet been defined and casualties are rumored | Vineyard

Orrego criticizes the Ministry of Development for tents in the Alameda: “They have been 1 year and there is no strategy” | National

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.